Gilead-Yuhan’s co-promotion agreement for Sovaldi and Harvoni
Gilead Sciences Korea(CEO Seung-Woo Lee) and Yuhan Corporation(CEO Jung-Hee Lee) announced a co-promotion ceremony of ‘Sovaldi’ and ‘Harvoni,’ chronic hepatitis C treatments, on the 31st of August.
The co-promotion agreement is a strategic partnership to jointly sell and market the Gilead’s chro...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
